The potential of lasmiditan in migraine

por Mecklenburg, Jasper, Raffaelli, Bianca, Neeb, Lars, Sanchez del Rio, Margarita, Reuter, Uwe
Publicado 2020

Benefit–Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm

por Citrome, Leslie, Sánchez del Rio, Margarita, Dong, Yan, Nichols, Russell M., Tockhorn-Heidenreich, Antje, Foster, Shonda A., Stauffer, Virginia L.
Publicado 2021

The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis

por Lampl, Christian, MaassenVanDenBrink, Antoinette, Deligianni, Christina I., Gil-Gouveia, Raquel, Jassal, Tanvir, Sanchez-del-Rio, Margarita, Reuter, Uwe, Uluduz, Derya, Versijpt, Jan, Zeraatkar, Dena, Sacco, Simona
Publicado 2023

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine

por Deligianni, Christina I., Sacco, Simona, Ekizoglu, Esme, Uluduz, Derya, Gil-Gouveia, Raquel, MaassenVanDenBrink, Antoinette, Ornello, Raffaele, Sanchez-del-Rio, Margarita, Reuter, Uwe, Versijpt, Jan, de Vries, Tessa, Hussain, Muizz, Zeraatkar, Dena, Lampl, Christian
Publicado 2023

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance

por Sacco, Simona, Lampl, Christian, Maassen van den Brink, Antoinette, Caponnetto, Valeria, Braschinsky, Mark, Ducros, Anne, Little, Patrick, Pozo-Rosich, Patricia, Reuter, Uwe, Ruiz de la Torre, Elena, Sanchez Del Rio, Margarita, Sinclair, Alexandra J., Martelletti, Paolo, Katsarava, Zaza
Publicado 2021

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline

por Lampl, Christian, Versijpt, Jan, Amin, Faisal Mohammad, Deligianni, Christina I., Gil-Gouveia, Raquel, Jassal, Tanvir, MaassenVanDenBrink, Antoinette, Ornello, Raffaele, Paungarttner, Jakob, Sanchez-del-Rio, Margarita, Reuter, Uwe, Uluduz, Derya, de Vries, Tessa, Zeraatkar, Dena, Sacco, Simona
Publicado 2023

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate

por Raffaelli, Bianca, García-Azorín, David, Boucherie, Deirdre M., Amin, Faisal Mohammad, Deligianni, Christina I., Gil-Gouveia, Raquel, Kirsh, Sarah, Lampl, Christian, Sacco, Simona, Uluduz, Derya, Versijpt, Jan, MaassenVanDenBrink, Antoinette, Zeraatkar, Dena, Sanchez-del-Rio, Margarita, Reuter, Uwe
Publicado 2023

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

por Sacco, Simona, Amin, Faisal Mohammad, Ashina, Messoud, Bendtsen, Lars, Deligianni, Christina I., Gil-Gouveia, Raquel, Katsarava, Zaza, MaassenVanDenBrink, Antoinette, Martelletti, Paolo, Mitsikostas, Dimos-Dimitrios, Ornello, Raffaele, Reuter, Uwe, Sanchez-del-Rio, Margarita, Sinclair, Alexandra J., Terwindt, Gisela, Uluduz, Derya, Versijpt, Jan, Lampl, Christian
Publicado 2022

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure

por Sacco, Simona, Lampl, Christian, Amin, Faisal Mohammad, Braschinsky, Mark, Deligianni, Christina, Uludüz, Derya, Versijpt, Jan, Ducros, Anne, Gil-Gouveia, Raquel, Katsarava, Zaza, Martelletti, Paolo, Ornello, Raffaele, Raffaelli, Bianca, Boucherie, Deirdre M., Pozo-Rosich, Patricia, Sanchez-del-Rio, Margarita, Sinclair, Alexandra, Maassen van den Brink, Antoinette, Reuter, Uwe
Publicado 2022